Travere Therapeutics Correlations

TVTX Stock

USD 21.08 0.55 2.68%

The correlation of Travere Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Travere Therapeutics Correlation With Market

Very weak diversification

The correlation between Travere Therapeutics and DJI is 0.42 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Travere Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Travere Stock please use our How to Invest in Travere Therapeutics guide.

Moving together with Travere Stock

0.83	PLX	Protalix Biotherapeutics	Pair Corr
0.64	LUCD	Lucid Diagnostics	Pair Corr
0.68	WM	Waste Management	Pair Corr
0.87	GE	GE Aerospace	Pair Corr
0.62	WMT	Walmart Aggressive Push	Pair Corr
0.74	CSCO	Cisco Systems	Pair Corr
0.75	MMM	3M Company	Pair Corr
0.78	JPM	JPMorgan Chase	Pair Corr
0.71	IBM	International Business	Pair Corr

Moving against Travere Stock

0.61	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.55	CDIO	Cardio Diagnostics	Pair Corr
0.49	SCLX	Scilex Holding	Pair Corr
0.39	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.33	CDIOW	Cardio Diagnostics	Pair Corr
0.33	ELVN	Enliven Therapeutics	Pair Corr
0.82	MRK	Merck Company	Pair Corr
0.32	MSFT	Microsoft	Pair Corr

Related Correlations Analysis

	DICE	CYTK	VTYX	COGT	NUVL	CERE	GPCR	RVMD	AKRO	RNA
DICE		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	DICE
CYTK	0.0		0.63	0.44	0.52	0.0	0.61	0.59	-0.19	0.02	CYTK
VTYX	0.0	0.63		0.43	0.53	0.0	0.83	0.8	-0.66	-0.04	VTYX
COGT	0.0	0.44	0.43		0.78	0.0	0.74	0.5	0.23	0.56	COGT
NUVL	0.0	0.52	0.53	0.78		0.0	0.77	0.7	0.12	0.65	NUVL
CERE	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	CERE
GPCR	0.0	0.61	0.83	0.74	0.77	0.0		0.75	-0.3	0.27	GPCR
RVMD	0.0	0.59	0.8	0.5	0.7	0.0	0.75		-0.3	0.33	RVMD
AKRO	0.0	-0.19	-0.66	0.23	0.12	0.0	-0.3	-0.3		0.54	AKRO
RNA	0.0	0.02	-0.04	0.56	0.65	0.0	0.27	0.33	0.54		RNA
	DICE	CYTK	VTYX	COGT	NUVL	CERE	GPCR	RVMD	AKRO	RNA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GPCR	+ 0.83	VTYX
RVMD	+ 0.8	VTYX
NUVL	+ 0.78	COGT
GPCR	+ 0.77	NUVL
RVMD	+ 0.75	GPCR
GPCR	+ 0.74	COGT

High negative correlations

AKRO	- 0.66	VTYX
AKRO	- 0.3	RVMD
AKRO	- 0.3	GPCR
AKRO	- 0.19	CYTK
RNA	- 0.04	VTYX
RNA	- 0.0	CERE

Risk-Adjusted Indicators

There is a big difference between Travere Stock performing well and Travere Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Travere Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DICE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CYTK	2.24	(0.04)	0.00	(0.19)	0.00	0.00	5.41	(4.22)	17.67
VTYX	3.35	(0.63)	0.00	(0.46)	0.00	0.00	6.88	(7.56)	27.07
COGT	2.97	(0.03)	0.00	(0.09)	0.00	0.00	6.97	(6.30)	17.21
NUVL	2.06	(0.08)	0.00	(0.16)	0.00	0.00	3.54	(5.19)	12.24
CERE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
GPCR	3.70	(0.37)	0.00	(0.27)	0.00	0.00	6.92	(10.88)	25.66
RVMD	1.71	(0.16)	0.00	(0.20)	0.00	0.00	4.37	(5.89)	11.35
AKRO	4.30	1.28	0.36	0.70	2.89	(5.76)	4.92	(5.64)	104.81
RNA	2.83	0.07	0.00	(0.02)	0.00	0.00	6.64	(4.79)	20.15

Travere Therapeutics Corporate Management

Elizabeth JD	General VP	Profile
Elizabeth Reed	General VP	Profile
William Rote	Senior Development	Profile
CFA CFA	Chief Officer	Profile
Angela Giannantonio	Senior Resources	Profile
Jula MD	Chief Officer	Profile
Casey Logan	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC